NATCAPSUQ

Natural Capsules Limited

· Pharma & Health
₹ CrorePeersNECLIFEAAREYDRUGSBALPHARMAALPAKREBSBIOMEDICAMEQMEDICOVINEETLAB
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation9.117.1
+ Finance Costs6.310.9
+ Share-based Payments0.32.2
+ Other Non-cash Items0.80.6
+ Other Reconciling Items-0.4-0.0
Changes in Working Capital
+ Inventories-6.4-0.9
+ Trade Receivables — Current-8.5-9.7
+ Other Financial Assets — Non-current-0.0-0.6
+ Other Current Assets0.32.3
+ Other Non-current Assets0.10.0
+ Other Bank Balances6.5-0.0
+ Trade Payables — Current8.116.8
+ Other Financial Liabilities — Current7.5-0.8
+ Other Current Liabilities1.84.0
+ Provisions — Current-0.50.5
+ Provisions — Non-current1.40.7
Cash from Operating Activities
Profit Before Tax (per I/S)2.8-27.9-27.7
+ Total Adjustments (incl. Working Capital)26.243.2
Cash from Operations (pre-tax)29.015.3
+ Interest Received — Operating-0.1-0.8
+ Income Taxes Paid2.13.6
Cash from Operating Activities26.810.9
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)44.611.5
+ Interest Received — Investing0.10.8
Cash from Investing Activities-44.5-10.8
Cash from Financing Activities
+ Proceeds from Issue of Shares27.80.0
+ Proceeds from Borrowings0.010.5
+ Repayment of Borrowings5.20.0
+ Payment of Lease Liabilities0.20.4
+ Interest Paid6.310.8
Cash from Financing Activities16.2-0.6
Net Changes in Cash (pre-FX)-1.6-0.5
Net Changes in Cash-1.6-0.5
Reference Items
EBITDA17.5-1.6-0.8
EBITDA Margin %10.35-0.83-0.40
Free Cash Flow (CFO − Capex)-17.9-0.6-0.6
Free Cash Flow to Equity-0.9
Free Cash Flow per Basic Share-17.21-0.59-0.59
Cash Flow to Net Income43.33-0.44
Cash Paid for Taxes2.13.6
Cash Paid for Interest6.310.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.